SCHWARZ BIOSCIENCES Successfully Implements VISTA for an EDC Clinical Study


Media, PA February 6, 2007 - Scientific Software Tools, Inc. (SST), a leader in the area of technology-enabling software and services for clinical trials, and SCHWARZ BIOSCIENCES, the research and development arm of SCHWARZ PHARMA, an innovative multi-national pharmaceutical company, announced today that SCHWARZ BIOSCIENCES has successfully utilized VISTA, a web-based investigative site technology assessment service, in a recent electronic data capture (EDC) clinical study.

PCs at remote investigative sites need to be technologically assessed before any EDC clinical study begins. This ensures that the site meets the hardware and software requirements of the study and is typically carried out via manual assessment surveys, which are slow, expensive, and often inaccurate.

According to Elise Furman, President of SST, "Site investigators and clinical staff often face frustration when conducting technology assessments of clinical study sites. Existing manual assessment methods tend to be time and labor-intensive, tedious and prone to inaccuracies, thus creating delays and problems for site investigators and clinical staff."

"VISTA is a web-based service designed specifically to solve these problems. It is a quick and easy way for non-technical users in clinical research to carry out the assessment process, leading to significant cost and time savings. Within seconds to minutes, VISTA accurately assesses, captures, and reports on the technology infrastructure of remote sites anywhere around the world. This is a service that is highly beneficial for pharmaceutical sponsors, CROs, and EDC providers."

Dave Wilson, Associate Director, Clinical Development Applications at SCHWARZ BIOSCIENCES, explains, "through the use of VISTA we were able to qualify the computers at our study sites without putting the site staff or our clinical staff in a position where they had to technically assess computers, a non-trivial task."

For more information regarding VISTA and how it might help pharmaceutical sponsors, CROs, EDC providers and investigative sites, visit www.vistasurveys.com, or contact Scientific Software Tools, Inc., at (610) 891-1640.

About SCIENTIFIC SOFTWARE TOOLS, INC.
Headquartered in suburban Philadelphia and founded in 1988 by a M.D. and R.N., Scientific Software Tools, Inc. provides software development services to customers in the pharmaceutical, CRO, manufacturing and healthcare industries

About SCHWARZ BIOSCIENCES and SCHWARZ PHARMA SCHWARZ BIOSCIENCES represents the research and development arm within the SCHWARZ PHARMA Group. SCHWARZ PHARMA (headquartered in Monheim, Germany) is a research driven pharmaceutical company with approximately 4,400 employees worldwide. The company develops novel medicines in the therapeutic areas of the central nervous system. Furthermore it markets innovative drugs focused to treat cardiovascular and gastro-intestinal diseases. In 2005 the SCHWARZ PHARMA group achieved global sales of nearly 1 billion. The company has a strong international presence with subsidiaries in Europe, USA and Asia.
www.schwarzpharma.com, contact: Antje Witte, Tel: +49 2173 48 1866

Contact Name: Elise Furman
Organization:
Title: President
E-mail: efurman@sstnet.com

All Topics